---
title: "The underlying index of the Sci-Tech Innovation Board Composite Index ETF Jianxin (589880) has risen 61.17% in the past year."
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40054935.md"
description: "As of 10:24, the SSE STAR Composite Index, which is tracked by the STAR Composite Index ETF Jianxin (589880), fell 1.71%. Wind data shows that as of April 20, the SSE STAR Composite Index has risen 61.17% in the past year; the STAR Composite Index ETF Jianxin (589880) has seen a net capital inflow of over 145 million yuan in the past 60 days. According to annual report data, the performance of listed companies on the STAR Market in 2025 was strong. Overall, the operating performance of the sector has rebounded significantly, with full-year operating revenue expected to reach 1.59 trillion yuan..."
datetime: "2026-04-21T03:40:13.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40054935.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40054935.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40054935.md)
author: "[同壁财经](https://longbridge.com/en/profiles/26505347.md)"
---

# The underlying index of the Sci-Tech Innovation Board Composite Index ETF Jianxin (589880) has risen 61.17% in the past year.

As of 10:24, the SSE STAR Market Composite Index tracked by the Kechuang Composite Index ETF Jianxin (589880) fell 1.71%.

Wind data shows that as of April 20, the SSE STAR Market Composite Index rose 61.17% in the past year; the Kechuang Composite Index ETF Jianxin (589880) saw net capital inflows exceeding 145 million in the past 60 days.

According to annual report data, STAR Market listed companies performed well in their 2025 annual results. Overall, the sector's operating performance rebounded significantly, with full-year operating revenue expected to reach 1.59 trillion yuan, a year-on-year increase of 10.3%; net profit reached 59.1 billion yuan, a year-on-year increase of 28.2%. Among them, over 70% of companies achieved revenue growth, nearly 60% saw year-on-year net profit growth, and 52 companies successfully turned losses into profits, demonstrating a strong recovery momentum.

Driven by strong emerging demand such as artificial intelligence, the integrated circuit industry maintained high prosperity. The combined revenue of 128 related enterprises increased by 25% year-on-year, and net profit surged by 83%, with over 60% of companies expecting profit growth or turning losses into profits.

The biopharmaceutical industry also performed impressively, with nearly 60% of 118 enterprises achieving net profit growth. Particularly, innovative drug companies saw combined revenue grow by 29.1% year-on-year and successfully achieved overall profitability, with combined net profit reaching 1.574 billion yuan, indicating a significant acceleration in the industry's commercialization process.

BOC Securities stated that it remains optimistic about the medium- to long-term value of A-shares. Compared horizontally with other global markets, the comparative advantages of A-shares in fundamentals and capital flows will gradually become apparent. Domestic fiscal policies implemented ahead of schedule are driving the sequential recovery of supply and demand fundamentals. Medium- to long-term capital entry plans for public funds, insurance, and other institutions, along with "quasi-stabilization funds," will provide bottom support for the market. In the long run, the weakening of the US dollar credit system will help reshape A-share valuations. Additionally, companies with positive profit warnings in their Q1 reports may indicate sector prosperity.

The SSE STAR Market Composite Index closely aligns with the core of technological innovation and national strategic emerging industry layouts. Its constituent stocks are highly concentrated in cutting-edge technology fields such as semiconductors, artificial intelligence, innovative drugs, and new energy, fully demonstrating the innovation vitality and development potential of China's hard-tech enterprises.

![image](https://pub.pbkrs.com/uploads/2026/ef50f2eec6b27670682525c56d47cfe5?x-oss-process=style/lg)

The management fee rate for the Kechuang Composite Index ETF Jianxin (589880) is 0.15%, the custody fee rate is 0.05%, and the total expense ratio is 0.2%, which is relatively low in the industry.

With its tracking of the STAR Market Composite Index, coverage of hard-tech sectors, and low-cost advantages, the Kechuang Composite Index ETF Jianxin (589880) has become a core tool for capturing China's technological innovation and industrial upgrading.

Related Products:

Kechuang Composite Index ETF Jianxin (589880)

Jianxin SSE STAR Market Composite Index Connect A (023743)

Jianxin SSE STAR Market Composite Index Connect C (023744)

Past index performance does not indicate future trends and does not represent the performance of related funds. The market carries risks, and investment requires caution.

### Related Stocks

- [000008.CN](https://longbridge.com/en/quote/000008.CN.md)
- [589880.CN](https://longbridge.com/en/quote/589880.CN.md)
- [000688.CN](https://longbridge.com/en/quote/000688.CN.md)